# Kai Zhao

> Kai Zhao is a startup investor at Cenova. See 0 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Cenova](https://shizune.co/investors/profile/cenova-ventures)
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/kaimzhao

Kai Zhao is a startup investor at Cenova. Dr. Zhao joined Cenova in 2014 as a partner. He brought in with him over 25 years' experience in healthcare management and investment. In particular, Dr. Zhao's intimate knowledge in hospital management and operations proved to be an invaluable asset for Cenova portfolios since hospitals are the single most important components of theChina's healthcare value chain.Before joining Cenova, Dr. Zhao co-founded two hospital management & investment firms, SinoCare and Beijing JiaheGuokang Hospital Management & Investment Co. Ltd. For the past 10 years, Dr. Zhao headed the acquisition and management of five hospitals in various parts of China, including four tier-2 hospitals and one tier-3 hospital. The acquired hospitals achieved significant revenue growth under his leadership within two years.Previously, Dr. Zhao served as a financial advisor for Ciming Checkup, currently one of the largest Chinese preventive healthcare companies, where he completed the A-round investment by CDH Fund. Before that, Dr. Zhao was the General Manager of Beijing Haiyinke Group, a bioscience investment firm and a leading biotech incubator in China. Prior to Haiyinke, Dr. Zhao served as the head of bioscience investment at the Beijing Science & Technology Venture Investment Co. Ltd., where he led the investment in over 10 life science and agriculture companies including Beilu Pharmaceuticals, Chipscreen, etc.. Earlier in his career, Dr. Zhao spent fourteen years practicing medicine and held various positions of increasing responsibilities at the General Hospital at Shenyang Military Region, a leading hospital in China.

## About Cenova

VC Fund · Shanghai, China

Cenova Capital is one of the earliest healthcare dedicated funds in China founded in 2010 by Dr Jun WU and is one of the earliest investors in private healthcare services and digital health, with helps to facilitate the transformation of healthcare in China from an exclusively state-owned system to a more efficient, market-oriented system. CenovaCapital is healthcare funds dedicated to early and growth-stage investments in the life sciences and healthcare sector in China. Since inception in 2010, Cenova now has five funds under management with investments in over 50 companies in healthcare services, pharmaceuticals, medical devices and digital heath. Cenova's investors are mainly large domestic and international institutional investors including Asian sovereign wealth funds, government institutions, insurance and financial institutions and multinational companies.

5 contacts available at Cenova.

| Name | Title | Profile |
| --- | --- | --- |
| Jun Wu | Founder and Chairman | https://shizune.co/investors/profile/jun-wu-3 |
| Kai Zhao | Managing Partner | https://shizune.co/investors/profile/kai-zhao-3 |
| Lehman Gu | Venture Partner | https://shizune.co/investors/profile/lehman-gu |
| Leo Li | Vice President | https://shizune.co/investors/profile/leo-li |
| Melissa Zhang | Vice President | https://shizune.co/investors/profile/melissa-zhang |

## FAQ

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co